0001646162-15-000001.txt : 20150804 0001646162-15-000001.hdr.sgml : 20150804 20150804145239 ACCESSION NUMBER: 0001646162-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150804 DATE AS OF CHANGE: 20150804 EFFECTIVENESS DATE: 20150804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ankasa Regenerative Therapeutics, Inc. CENTRAL INDEX KEY: 0001646162 IRS NUMBER: 471928158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-245063 FILM NUMBER: 151025100 BUSINESS ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858 750 4739 MAIL ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 290 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0707 D LIVE 0001646162 Ankasa Regenerative Therapeutics, Inc. 11099 N. TORREY PINES ROAD SUITE 290 LA JOLLA CA CALIFORNIA 92037 858 750 4739 DELAWARE None None Corporation true 2014 Sanford J. Madigan Ankasa Regenerative Therapeutics, Inc. 11099 N. Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Douglas Downs Ankasa Regenerative Therapeutics, Inc. 11099 N. Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Kevin Kinsella Ankasa Regenerative Therapeutics, Inc. 11099 N. Torrey Pines Road, Suite 290 La Jolla CA CALIFORNIA 92037 Director Pharmaceuticals Decline to Disclose 06b false 2015-05-29 false true false 0 19998970 9518966 10480004 false 5 0 0 0 false Ankasa Regenerative Therapeutics, Inc. Sanford J. Madigan, Ph.D. Sanford J. Madigan, Ph.D. President and CEO 2015-07-30